KURA FY 2022 Earnings — Kura Oncology, Inc. Revenue & Financial Results | Market Cap Arena

KURAKura Oncology, Inc.

$815M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$140M

Net Income

-$136M

EPS (Diluted)

$-2.03

Cash Flow

Operating Cash Flow

-$110M

Free Cash Flow

-$111M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$456M

Total Liabilities

$36M

Stockholders' Equity

$420M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$140M	-$131M	-6.6%
Net Income	-$136M	-$130M	-4.1%